Food and Drug Administration
Antiviral Drugs Advisory Committee
March 19, 2002
NDA
21-245, Picovir™ (pleconaril), ViroPharma Incorporated, proposed
for treatment of acute picornaviral upper respiratory illness (common cold) in
adults
Slides
Sponsor Presentation - ViroPharma Incorporated ppt htm
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.